𝔖 Bobbio Scriptorium

✦ LIBER ✦

Development of Resistance to Oxoglaucine in Poliovirus Type 1 (LSc-2ab) and the Six Coxsackie B Viruses

✍ Scribed by Lubomira Nikolaeva-Glomb; Angel S. Galabov

Book ID: 113457791
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 65 KB
Volume: 78
Category: Article
ISSN: 0166-3542
DOI: 10.1016/j.antiviral.2008.01.131

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

55 Selection of human immunodeficiency v

55 Selection of human immunodeficiency virus type 1 (Hiv-1) resistant to the nucleoside inhibitor 2′,3′-dideoxy-5-fluoro-3′-thiacytidine (Ftc) in cell culture due to a single mutation in the reverse transcriptase: M. Tisdale, N. R. Parry, S. D. Kemp and B. A. Larder, Department of Molecular Sciences, The Wellcome Research Laboratories, Beckenham, Kent BR3 3BS, U.K.

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 65 KB

61 Comparative rates of in vitro resista

61 Comparative rates of in vitro resistance development of HIV-1 to new non-nucleoside analog RT inhibitors: L. Vrang1, C. Rydergard1, C. Ahgren1, P. Engelhardt1, M. Hogberg1, N. G. Johansson1, J. Kangasmetsa1, P. Lind1, R. Noreen1, C. Sahlberg1, X.-X. Zhou1, A. Karlsson2, C. Lopez3, J. M. Morin, Jr.3, R. J. Ternansky3, F. W. Bell3, C. L. Jordan3, M. D. Kinnick3, J. A. Palkowitz3, C. A. Parrish3, P. Pranc3, R. T. Vasileff3, S. J. West3, and B. Oberg1. 1Medivir AB, Huddinge, Sweden; 2Department of Biochemistry, Stockholm, Sweden; 3Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 81 KB